Search research articles
Contact Us
Filters
Showing results (201-210 of 252) with videos related to
Page
of 26
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
June 29, 2026
Mapping the anatomical landscape of colorectal tumours: Location-specific efficacy of anti-epidermal growth factor receptor antibodies: Pooled analysis of randomised trials
Kenta Iguchi, Kentaro Yamazaki, Toshihiro Misumi, et al.
Journal of the Anus, Rectum and Colon
|
May 1, 2024
Monitoring ctDNA RAS Mutational Status in Metastatic Colorectal Cancer: A Trial Protocol of RAS-trace and RAS-trace-2 Studies
Kozo Kataoka, Takeshi Yamada, Manabu Shiozawa, et al.
Current Medical Research and Opinion
|
July 7, 2021
Clinical development and evaluation of a VEGF-D assay in plasma from patients with metastatic colorectal cancer in the RAISE study
Hiroya Taniguchi, Takayuki Yoshino, Kensei Yamaguchi, et al.
International Journal of Clinical Oncology
|
May 9, 2024
The efficacy and safety of anamorelin among patients with diabetes
Kenju Ando, Tateaki Naito, Satoshi Hamauchi, et al.
The Lancet. Oncology
|
April 17, 2015
Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study
Josep Tabernero, Takayuki Yoshino, Allen Lee Cohn, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
December 31, 2024
Prevalence and clinicopathological features of microsatellite instability-high metastatic or recurrent gastric and esophagogastric junction cancer: WJOG13320GPS
Azusa Komori, Shuichi Hironaka, Shigenori Kadowaki, et al.
Cancer Chemotherapy and Pharmacology
|
July 27, 2017
Exposure-response relationship of ramucirumab in patients with advanced second-line colorectal cancer: exploratory analysis of the RAISE trial
Allen Lee Cohn, Takayuki Yoshino, Volker Heinemann, et al.
Cancer Science
|
January 19, 2019
Phase II trial of aflibercept with FOLFIRI as a second-line treatment for Japanese patients with metastatic colorectal cancer
Tadamichi Denda, Daisuke Sakai, Tetsuya Hamaguchi, et al.
The Journal of Liquid Biopsy
|
March 3, 2025
Validity and utility of blood tumor mutational burden (bTMB) is dependent on circulating tumor DNA (ctDNA) shed: SCRUM-Japan MONSTAR-SCREEN
Saori Mishima, Yoshiaki Nakamura, Hanna Tukachinsky, et al.
Biomedical Reports
|
October 1, 2019
Histopathological factors affecting the extraction of high quality genomic DNA from tissue sections for next-generation sequencing
Satoshi Fujii, Takayuki Yoshino, Kentaro Yamazaki, et al.
Page
of 26
Search research articles
Search
Showing results (201-210 of 252) with videos related to
Sort By:
Page
of 26
European Journal of Cancer (Oxford, England : 1990)
|
June 29, 2026
Mapping the anatomical landscape of colorectal tumours: Location-specific efficacy of anti-epidermal growth factor receptor antibodies: Pooled analysis of randomised trials
Kenta Iguchi, Kentaro Yamazaki, Toshihiro Misumi, et al.
Journal of the Anus, Rectum and Colon
|
May 1, 2024
Monitoring ctDNA RAS Mutational Status in Metastatic Colorectal Cancer: A Trial Protocol of RAS-trace and RAS-trace-2 Studies
Kozo Kataoka, Takeshi Yamada, Manabu Shiozawa, et al.
Current Medical Research and Opinion
|
July 7, 2021
Clinical development and evaluation of a VEGF-D assay in plasma from patients with metastatic colorectal cancer in the RAISE study
Hiroya Taniguchi, Takayuki Yoshino, Kensei Yamaguchi, et al.
International Journal of Clinical Oncology
|
May 9, 2024
The efficacy and safety of anamorelin among patients with diabetes
Kenju Ando, Tateaki Naito, Satoshi Hamauchi, et al.
The Lancet. Oncology
|
April 17, 2015
Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study
Josep Tabernero, Takayuki Yoshino, Allen Lee Cohn, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
December 31, 2024
Prevalence and clinicopathological features of microsatellite instability-high metastatic or recurrent gastric and esophagogastric junction cancer: WJOG13320GPS
Azusa Komori, Shuichi Hironaka, Shigenori Kadowaki, et al.
Cancer Chemotherapy and Pharmacology
|
July 27, 2017
Exposure-response relationship of ramucirumab in patients with advanced second-line colorectal cancer: exploratory analysis of the RAISE trial
Allen Lee Cohn, Takayuki Yoshino, Volker Heinemann, et al.
Cancer Science
|
January 19, 2019
Phase II trial of aflibercept with FOLFIRI as a second-line treatment for Japanese patients with metastatic colorectal cancer
Tadamichi Denda, Daisuke Sakai, Tetsuya Hamaguchi, et al.
The Journal of Liquid Biopsy
|
March 3, 2025
Validity and utility of blood tumor mutational burden (bTMB) is dependent on circulating tumor DNA (ctDNA) shed: SCRUM-Japan MONSTAR-SCREEN
Saori Mishima, Yoshiaki Nakamura, Hanna Tukachinsky, et al.
Biomedical Reports
|
October 1, 2019
Histopathological factors affecting the extraction of high quality genomic DNA from tissue sections for next-generation sequencing
Satoshi Fujii, Takayuki Yoshino, Kentaro Yamazaki, et al.
Page
of 26